■ Contemporary surgical treatment of benign prostatic hyperplasia
Nunes, Ricardo Luís Vita, Antunes, Alberto Azoubel and Constantin, Davi Souza
Rev. Assoc. Med. Bras., Aug 2017, vol.63, no.8, p.711-71
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0104-42302017000800711&lng=pt&nrm=iso
■ Singapore Urological Association Clinical Guideline for male lower urinary tract symptoms/benign prostatic hyperplasia
Singapore Med J. 2017, vol 58(8): 473–480
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5563527/
■ Pharmacologic therapy in mens´s health: hypogonadism, erectile dysfunction, and benign prostatic hyperplasia
Kathryn E. Berkseth, Arthi Thirumalai, John K. Amory
Med Clin North Am. 2016 Jul; 100(4): 791–805
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5639879/
■ 5alpha-reductase inhibitors for treatment of benign prostatic hyperplasia: a systematic review and meta-analysis
Jennifer E J Jun, Angus Kinkade, Anthony C H Tung, Aaron M Tejani
Can J Hosp Pharm. 2017 , vol 70(2): 113–119
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5407420/
■ Benign prostatic hyperplasia: review of modern minimally invasive surgical treatments
Tony Nimeh, Brenden Magnan, Y. Zaki Almallah
Semin Intervent Radiol. 2016 Sep; 33(3): 244–25
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5005077/
■ Minimally invasive surgical therapies for benign prostatic hypertrophy: the rise in minimally invasive surgical therapies
Daniel Christidis, Shannon McGrath, Marlon Perera et al
Prostate Int. 2017 , vol 5(2): 41–46
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5448728/
■ Medical and surgical treatment modalities for lower urinary tract symptoms in the male patient secondary to benign prostatic hyperplasia: a review
Matthew Ryan Macey, Mathew C. Raynor
Semin Intervent Radiol. 2016 Sep; 33(3): 217–223
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5005076/
■ Inflammation in prostatic hyperplasia and carcinoma-basic scientific approach
Božo Krušlin, Davor Tomas, Tihana Džombeta, Marija Milković-Periša, Monika Ulamec
Front Oncol. 2017; vol 7: 7
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5403898/
■ Randomized, controlled Trial of laser vs. bipolar plasma vaporization treatment of benign prostatic hyperplasia
Thomas A.A. Skinner, Robert J. Leslie, Stephen S. Steele, J. Curtis Nickel
Can Urol Assoc J. 2017 vol 11(6): 194–198
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5472465/
■ Pulsed electromagnetic field with or withou exercise therapy in the treatment of benign prostatic hyperplasia
Hany M Elgohary, Sayed A Tantawy
J Phys Ther Sci. 2017, vol 29(8): 1305–1310
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5574357/
■ Correlation of subjective symptoms in patients with benign prostatic hyperplasia and erectile dysfunction
Amel Kardasevic, Snjezana Milicevic
Med Arch. 2017, vol 71(1): 32–36.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5364794/
■ Comparison of tamsulosin and silodosin in the management of acute urinary retention secondary to benign prostatic hyperplasia in patients planned for trial without catheter. A prospective randomized study
Siddangouda B. Patil, Kshitiz Ranka, Vinay S. Kundargi, Nilesh Guru
Cent European J Urol. 2017; vol 70(3): 259–263
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5656367/
■ Preliminary assessment of neck circumference in benign prostatic hyperplasia in patients with metabolic syndrome
Akin, Yigit et al.
Int. braz j urol., Feb 2017, vol.43, no.1, p.95-103
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1677-55382017000100095&lng=en&nrm=iso
■ Undertanding patient and physician perceptions of benign prostatic hyperplasia in Asia Pacific, Latin Americam and the Commonwealth of Independent States: the Prostate Research on Behaviour and Education (PROBE) II survey
P Ertel, B Adalig, I Dermican, B Lartey
Clinical Practive 2016, vol 70 (10): 870-880
http://onlinelibrary.wiley.com/doi/10.1111/ijcp.12879/full
■ Clinical importance of histopathological inflammation in patients with lower urinary tract symptoms due to benign prostatic hyperplasia: a prospective study of 222 patients
Thibault Meert, Evert Baten, Koenraad van Renterghem
Curr Urol. 2017 Aug; 10(3): 150–153
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5582431/
■ Common question about the diagnosis and management of benign prostatic hyperplasia
R Pearson, Pamela M Williams
Am Fam Physician 2014, vol 90 (11): 769-774
http://www.aafp.org/afp/2014/1201/p769.html
■ by Dr Paulo Fernando Leite
Cardiologia – Centro Médico Unimed BH
Rua Gonçalves Dias 202
Belo Horizonte/MG/Brasil
31 30033306 / 40204020
CRMMG: 7026
Email: pfleite1873@gmail.com